LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 13 of 497
Next
>>
>
301 to 325 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	TGX221	0.04	uM	LJP5	1	H24	72	hr	1657	5532	5505	1.0048	1.0068
BT-20	TGX221	0.04	uM	LJP5	2	H24	72	hr	1657	4894	5505	0.8889	0.8410
BT-20	TGX221	0.04	uM	LJP5	3	H24	72	hr	1657	5322	5505	0.9666	0.9523
BT-20	Torin1	0.04	uM	LJP6	1	O18	72	hr	1657	2261	5505	0.4107	0.1568
BT-20	Torin1	0.04	uM	LJP6	2	O18	72	hr	1657	2593	5505	0.4710	0.2431
BT-20	Torin1	0.04	uM	LJP6	3	O18	72	hr	1657	2482	5505	0.4508	0.2142
BT-20	Torin2	0.04	uM	LJP5	1	I24	72	hr	1657	1771	5505	0.3217	0.0294
BT-20	Torin2	0.04	uM	LJP5	2	I24	72	hr	1657	1690	5505	0.3070	0.0084
BT-20	Torin2	0.04	uM	LJP5	3	I24	72	hr	1657	1732	5505	0.3146	0.0193
BT-20	Tozasertib	0.04	uM	LJP5	1	B18	72	hr	1657	3624	5505	0.6582	0.5110
BT-20	Tozasertib	0.04	uM	LJP5	2	B18	72	hr	1657	2951	5505	0.5360	0.3361
BT-20	Tozasertib	0.04	uM	LJP5	3	B18	72	hr	1657	3463	5505	0.6290	0.4692
BT-20	Trametinib	0.04	uM	LJP5	1	P24	72	hr	1657	4104	5505	0.7454	0.6357
BT-20	Trametinib	0.04	uM	LJP5	2	P24	72	hr	1657	4134	5505	0.7509	0.6435
BT-20	Trametinib	0.04	uM	LJP5	3	P24	72	hr	1657	3889	5505	0.7064	0.5799
BT-20	TWS119	0.04	uM	LJP5	1	M06	72	hr	1657	5266	5505	0.9565	0.9377
BT-20	TWS119	0.04	uM	LJP5	2	M06	72	hr	1657	5976	5505	1.0854	1.1222
BT-20	TWS119	0.04	uM	LJP5	3	M06	72	hr	1657	5421	5505	0.9846	0.9780
BT-20	Vemurafenib	0.04	uM	LJP5	1	C18	72	hr	1657	5409	5505	0.9824	0.9749
BT-20	Vemurafenib	0.04	uM	LJP5	2	C18	72	hr	1657	5507	5505	1.0002	1.0003
BT-20	Vemurafenib	0.04	uM	LJP5	3	C18	72	hr	1657	6282	5505	1.1410	1.2018
BT-20	Withaferin A	0.04	uM	LJP5	1	G18	72	hr	1657	5964	5505	1.0832	1.1191
BT-20	Withaferin A	0.04	uM	LJP5	2	G18	72	hr	1657	5318	5505	0.9659	0.9512
BT-20	Withaferin A	0.04	uM	LJP5	3	G18	72	hr	1657	5801	5505	1.0536	1.0768
BT-20	Withaferin A	0.04	uM	LJP6	1	G18	72	hr	1657	5764	5505	1.0469	1.0671

|<
<<
Previous
Page 13 of 497
Next
>>
>
301 to 325 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)